Details of Drug

Drug General Information (ID: D1039)
Drug Name	Methylphenidate
Drug Type	Small molecule
Drug Synonymous	Calocain; Centedein; Centedrin; Centredin; Concerta; Daytrana; Meridil; Metadate; Methylfenidan; Methylin; Methylofenidan; Methylphen; Methylphenidan; Methylphenidatum; Metilfenidato; Phenidylate; Plimasine; Riphenidate; Ritalin; Ritaline; Tsentedrin; Metadate CD; Metadate ER; Methyl phenidate; Methyl phenidyl acetate; Methyl phenidylacetate; Methylin ER; Metilfenidato [Italian]; Ritalin LA; Ritalin SR; Ritcher works; C 4311; Attenta (TN); Biphentin (TN); Concerta (TN); D-methylphenidate HCl; Daytrana (TN); Equasym (TN); Metadate ER (TN); Methylin (TN); Methylphenidate [INN:BAN]; Methylphenidatum [INN-Latin]; Metilfenidato [INN-Spanish]; Motiron (TN); PMS-Methylphenidate; Ritalin (TN); Ritalin LA (TN); Ritalin-SR; Rubifen (TN); Methylphenidate (USAN/INN); Alpha-Phenyl-2-piperidineacetic acid methyl ester; Methyl phenyl(piperidin-2-yl)acetate; Methyl alpha-phenyl-alpha-2-piperidinylacetate; Alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester; Methyl 2-phenyl-2-piperidin-2-ylacetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; Methyl (2-phenyl-2-(2-piperidyl)acetate); METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R); 2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester Click to Show/Hide
Disease Class	6A05: Attention deficit hyperactivity disorder; NA07: Intracranial injury
Therapeutic Class	Cns Stimulants
Structure
Structure	3D Structure		2D Structure
Formula	C14H19NO2
InChI	1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3
InChIKey	DUGOZIWVEXMGBE-UHFFFAOYSA-N
Canonical SMILES	COC(=O)C(C1CCCCN1)C2=CC=CC=C2
External Link
	Pubchem ID	4158
	CAS Number	113-45-1
	CHEBI ID	84276
	TTD ID	D02PPN
	INTEDE ID	DR1054
	VARIDT ID	DR00389

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM014 Interference of cell/tissue uptake BM017 CYP450 enzyme inhibition BM025 Decreased metabolism (Unspecific) BM038 Additive CNS depression effects BM041 Additive hypertensive effects BM061 Increased risk of hyperpyrexia BM069 Increased risk of lowers seizure threshold BM089 Antagonize the effect of antihypertensive agents BM093 Antagonize the effect of dopaminergic agents
Relation Graph

Full list of drugs interacting with Methylphenidate
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0829		Iobenguane (I-131)	C8H10IN3	60860	Major		Inter Info	[21]
D1821		Iobenguane (I-123)	C8H10IN3	60860	Moderate		Inter Info	[146], [147], [148]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0697		Fosphenytoin	C16H15N2O6P	56339	Minor		Inter Info	[155], [156], [157], [158], [40], [41]
D1265		Phenobarbital	C12H12N2O3	4763	Minor		Inter Info	[155], [156], [157], [158], [40], [41]
D1340		Primidone	C12H14N2O2	4909	Minor		Inter Info	[155], [156], [157], [158], [40], [41]
D1283		Phenytoin	C15H12N2O2	1775	Minor		Inter Info	[155], [156], [157], [158], [40], [41]
	Decreased metabolism (Unspecific)					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D0345		Citalopram	C20H21FN2O	2771	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[41]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[93], [94], [95], [96], [97], [40], [98], [99]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[86], [87], [88], [89], [90], [91], [92]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[100], [97], [136]
	Additive hypertensive effects					Drug Num: 38
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0377		Cocaine (nasal)	C17H21NO4	446220	Major		Inter Info	[16], [17], [18]
D0378		Cocaine (topical)	C17H21NO4	446220	Major		Inter Info	[16], [17], [18]
D0600		Esketamine	C13H16ClNO	182137	Major		Inter Info	[19], [20]
D1437		Safinamide	C17H19FN2O2	131682	Major		Inter Info	[27], [49], [28], [16], [51], [29], [30], [52], [32], [33], [53], [34], [54], [55], [35], [60], [36], [61], [81], [43], [82], [44], [46], [83], [47], [48]
D0570		Enflurane	C3H2ClF5O	3226	Moderate		Inter Info	[19], [16], [100]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[40], [42], [104]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[40], [42], [104]
D0445		Desflurane	C3H2F6O	42113	Moderate		Inter Info	[19], [16], [100]
D0510		Dobutamine	C18H23NO3	36811	Moderate		Inter Info	[40], [42], [104]
D0517		Dopamine	C8H11NO2	681	Moderate		Inter Info	[40], [42], [104]
D0579		Ephedrine	C10H15NO	9294	Moderate		Inter Info	[40], [42], [104]
D0581		Epinephrine	C9H13NO3	5816	Moderate		Inter Info	[40], [42], [104]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[40], [42], [104]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[19], [16], [100]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[40], [42], [104]
D0855		Isoflurane	C3H2ClF5O	3763	Moderate		Inter Info	[19], [16], [100]
D0857		Isometheptene	C9H19N	22297	Moderate		Inter Info	[40], [42], [104]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[40], [42], [104]
D0921		Levonordefrin	C9H13NO3	164739	Moderate		Inter Info	[40], [42], [104]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[40], [42], [104]
D1002		Mephentermine	C11H17N	3677	Moderate		Inter Info	[40], [42], [104]
D1013		Metaraminol	C9H13NO2	5906	Moderate		Inter Info	[40], [42], [104]
D1027		Methoxamine	C11H17NO3	6082	Moderate		Inter Info	[40], [42], [104]
D1030		Methoxyflurane	C3H4Cl2F2O	4116	Moderate		Inter Info	[19], [16], [100]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[40], [42], [104]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[40], [42], [104]
D1363		Pseudoephedrine	C10H15NO	7028	Moderate		Inter Info	[40], [42], [104]
D1374		Racepinephrine	C9H13NO3	838	Moderate		Inter Info	[40], [42], [104]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[27], [49], [28], [16], [51], [29], [30], [52], [32], [33], [53], [34], [54], [55], [35], [60], [36], [61], [81], [43], [44], [46], [83], [47], [48]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[40], [42], [104]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[40], [42], [104]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[40], [42], [104]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[19], [16], [100]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[40], [42], [104]
D1061		Midodrine	C12H18N2O4	4195	Moderate		Inter Info	[16], [154]
D1153		Norepinephrine	C8H11NO3	439260	Moderate		Inter Info	[40], [42], [104]
D1276		Phenylephrine	C9H13NO2	6041	Moderate		Inter Info	[40], [42], [104]
D1281		Phenylpropanolamine	C9H13NO	26934	Moderate		Inter Info	[40], [42], [104]
	Increased risk of hyperpyrexia					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0853		Isocarboxazid	C12H13N3O2	3759	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D0933		Linezolid	C16H20FN3O4	441401	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D1036		Methylene blue	C16H18ClN3S	6099	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[27], [49], [28], [19], [16], [50], [51], [29], [30], [52], [31], [32], [33], [53], [34], [54], [55], [56], [57], [58], [35], [59], [60], [36], [61], [62], [63], [64], [37], [38], [65], [66], [39], [40], [67], [68], [69], [41], [70], [71], [42], [72], [43], [73], [44], [45], [74], [75], [46], [47], [76], [77], [78], [48]
D1263		Phenelzine	C8H12N2	3675	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D1345		Procarbazine	C12H19N3O	4915	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D1455		Selegiline	C13H17N	26757	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D1620		Tranylcypromine	C9H11N	19493	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
	Increased risk of lowers seizure threshold					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0220		Bupropion	C13H18ClNO	444	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[22], [23], [24], [25], [26]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[22], [23], [24], [25], [26]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[84], [14], [13], [85]
D0054		Amifampridine	C5H7N3	5918	Moderate		Inter Info	[107], [108]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[137], [138], [139], [140], [141], [142], [143], [144]
D0932		Lindane	C6H6Cl6	727	Moderate		Inter Info	[149], [150], [151]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[152], [153], [16]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[152], [153], [16]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[152], [153], [16]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antihypertensive agents					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0743		Guanadrel	C10H19N3O2	38521	Moderate		Inter Info	[101], [102], [103]
D0058		Amiloride	C6H8ClN7O	16231	Moderate		Inter Info	[19], [16], [109]
D0444		Deserpidine	C32H38N2O8	8550	Moderate		Inter Info	[101], [102], [103]
D0567		Enalapril	C20H28N2O5	5388962	Moderate		Inter Info	[19], [16], [109]
D0744		Guanethidine	C10H22N4	3518	Moderate		Inter Info	[101], [102], [103]
D0771		Hydrochlorothiazide	C7H8ClN3O4S2	3639	Moderate		Inter Info	[19], [16], [109]
D0775		Hydroflumethiazide	C8H8F3N3O4S2	3647	Moderate		Inter Info	[19], [16], [109]
D1311		Polythiazide	C11H13ClF3N3O4S3	4870	Moderate		Inter Info	[19], [16], [109]
D1393		Reserpine	C33H40N2O9	5770	Moderate		Inter Info	[101], [102], [103]
	Antagonize the effect of dopaminergic agents					Drug Num: 16
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[79], [80]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[105], [36], [106]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D0750		Haloperidol	C21H23ClFNO2	3559	Moderate		Inter Info	[110], [111], [145], [112], [114], [115], [116], [117], [118], [105], [119], [120], [121], [122], [123], [124], [38], [43], [106], [132], [133], [134], [135]
D1010		Mesoridazine	C21H26N2OS2	4078	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1019		Methdilazine	C18H20N2S	14677	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1355		Propiomazine	C20H24N2OS	4940	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1574		Thioridazine	C21H26N2S2	5452	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]
D1572		Thiethylperazine	C22H29N3S2	5440	Moderate		Inter Info	[110], [111], [112], [113], [114], [115], [116], [117], [118], [105], [119], [120], [36], [121], [122], [123], [124], [38], [125], [126], [39], [127], [128], [40], [129], [41], [130], [131], [43], [106], [132], [133], [134], [135]

References
1	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
2	Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
3	Canadian Pharmacists Association.
4	Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
5	Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
6	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
7	James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
8	Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
9	Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
10	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
11	Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
12	Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
13	Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
14	Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
15	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
16	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
17	Thevasagyam M, Jindal M, Allsop P, Oates J "Does epinephrine infiltration in septoplasty make any difference?" Eur Arch Otorhinolaryngol 264 (2007): 1175-8.[PMID: 17530270]
18	Product Information. Cocaine Hydrochloride (cocaine topical). Mallinckrodt Medical Inc, St. Louis, MO.
19	Cerner Multum, Inc. "Australian Product Information.".
20	Product Information. Spravato (esketamine). Janssen Pharmaceuticals, Titusville, NJ.
21	Product Information. Azedra (iobenguane I-131). Progenics Pharmaceuticals, Inc., New York, NY.
22	Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
23	Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
24	Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
25	Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
26	Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
27	Ban TA "Drug interactions with psychoactive drugs." Dis Nerv Syst 36 (1975): 164-6. [PMID: 1116424]
28	Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Pritchard BN "Interactions between sympathomimetic amines and antidepressant agents in man." Br Med J 1 (1973): 311-5. [PMID: 4685619]
29	FISCHER E, ORLANDO J, LUDMER RL. INFLUENCIA DE METILANFETAMINA, IPRONIACIDA Y TRANILCIPROMINA SOBRE LA DEPRESI'ON PSICOMOTORA ADRENAL'INICA [EFFECT OF METHYLAMPHETAMINE, IPRONIAZID AND TRANYLCYPROMINE ON ADRENALINE PSYCHOMOTOR DEPRESSION]. Prensa Med Argent. 1964;51:1538-1540. [PMID: 14272082]
30	Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31. [PMID: 8845455]
31	De Vita VT, Hahn MA, Oliverio VT "Monoamine oxidase inhibition by a new carcinostatic agent, n-isopropyl-a-(2-methylhydrazino)-p-toluamide (MIH). (30590)." Proc Soc Exp Biol Med 120 (1965): 561-5. [PMID: 4379192]
32	Elis J, Laurence DR, Mattie H, Prichard BN "Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure." Br Med J 2 (1967): 75-8. [PMID: 6020852]
33	Goldberg LI "Monoamine oxidase inhibitors: adverse reactions and possible mechanisms." JAMA 190 (1964): 456-62. [PMID: 14197995]
34	Harrison WM, McGrath PJ, Stewart JW, Quitkin F "MAOIs and hypertensive crises: the role of OTC drugs." J Clin Psychiatry 50 (1989): 64-5. [PMID: 2464583]
35	Krisko I, Lewis E, Johnson JE "Severe hyperpyrexia due to tranylcypromine-amphetamine toxicity." Ann Intern Med 70 (1969): 559-64. [PMID: 5775035]
36	Markowitz JS, Patrick KS "Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder." Clin Pharmacokinet 40 (2001): 753-72. [PMID: 11707061]
37	Pettinger WA, Soyangco FG, Oates JA "Inhibition of monoamine oxidase in man by furazolidone." Clin Pharmacol Ther 9 (1968): 442-7. [PMID: 5655478]
38	Product Information. Adderall (amphetamine-dextroamphetamine) Shire Richwood Pharmaceutical Company, Florence, KY.
39	Product Information. Dexedrine (dextroamphetamine) SmithKline Beecham, Philadelphia, PA.
40	Product Information. Focalin (dexmethylphenidate). Mikart Inc, Atlanta, GA.
41	Product Information. Ritalin (methylphenidate). Novartis Pharmaceuticals, East Hanover, NJ.
42	Product Information. Strattera (atomoxetine). Lilly, Eli and Company, Indianapolis, IN.
43	Product Information. Vyvanse (lisdexamfetamine). Shire US Inc, Florence, KY.
44	Schildkraut JJ, Klerman GL, Friend DG, Greenblatt M "Biochemical and pressor effects of oral d,l-dihydroxyphenylalanine in patients pretreated with antidepressant drugs." Ann N Y Acad Sci 107 (1963): 1005-15. [PMID: 13991689]
45	Schulz R, Antonin KH, Hoffmann E, et al "Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline." Clin Pharmacol Ther 46 (1989): 528-36. [PMID: 2510962]
46	Sjoqvist F "Psychotropic drugs (2) interaction between monoamine oxidase (MAO) inhibitors and other substances." Proc R Soc Med 58 (1965): 967-78. [PMID: 4952963]
47	Smookler S, Bermudez AJ "Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant." Ann Intern Med 11 (1982): 482-4. [PMID: 7114595]
48	Wright SP "Hazards with monoamine-oxidase inhibitors: a persistent problem." Lancet 1 (1978): 284-5. [PMID: 74715]
49	Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Prichard BN "Interactions between sympathomimetic amines and antidepressant agents in man." Br Med J 1 (1973): 311-5. [PMID: 4685619]
50	Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR "Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine." Arch Ophthalmol 108 (1990): 1264-7. [PMID: 2205182]
51	Cuthbert MF, Greenberg MP, Morley SW "Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors." Br Med J 1 (1969): 404-6. [PMID: 5763957]
52	Davies B, Bannister R, Sever P "Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure: limitations and hazards." Lancet 1 (1978): 172-5. [PMID: 74603]
53	Goulet JP, Perusse R, Turcotte JY "Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions." Oral Surg Oral Med Oral Pathol 74 (1992): 692-7. [PMID: 1359489]
54	Horler AR, Wynne NA "Hypertensive crisis due to pargyline and metaraminol." Br Med J 5459 (1965): 460-1. [PMID: 14314914]
55	Humberstone PM "Hypertension from cold remedies." Br Med J 1 (1969): 846. [PMID: 5813090]
56	Hunter KR, Boakes AJ, Laurence DR, Stern GM "Monoamine oxidase inhibitors and L-dopa." Br Med J 3 (1970): 388. [PMID: 5451592]
57	King MH, Richards DW "Near syncope and chest tightness after administration of apraclonidine before argon laser iridotomy." Am J Ophthalmol 110 (1990): 308-9. [PMID: 2204271]
58	Kraft KE, Dore FH "Computerized drug interaction programs: how reliable?." JAMA 275 (1996): 1087. [PMID: 8601924]
59	Kronig MH, Roose SP, Walsh BT, Woodring S, Glassman AH "Blood pressure effects of phenelzine." J Clin Psychopharmacol 3 (1983): 307-10. [PMID: 6630590]
60	Lefebvre H, Noblet C, Morre N, Wolf LM "Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline." Clin Endocrinol (Oxf) 42 (1995): 95-8. [PMID: 7889639]
61	Mason AM, Buckle RM ""Cold" cures and monoamine-oxidase inhibitors." Br Med J 1 (1969): 845-6. [PMID: 5813089]
62	Nordlund JR, Pasquale LR, Robin AL, Rudikoff MT, Ordman J, Chen KS, Walt J "The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine." Arch Ophthalmol 113 (1995): 77-83. [PMID: 7826297]
63	Paykel ES "Hallucinosis on combined methyldopa and pargyline." Br Med J 1 (1966): 803. [PMID: 5910115]
64	Pekdemir M, Yanturali S, Karakus G "More than just an ocular solution." Emerg Med J 22 (2005): 753-4. [PMID: 16189050]
65	Product Information. Aldomet (methyldopa). Merck & Co, Inc, West Point, PA.
66	Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
67	Product Information. Iopidine (apraclonidine). Alcon Laboratories Inc, Fort Worth, TX.
68	Product Information. Mirvaso (brimonidine topical). Galderma Laboratories Inc, Cranbury, NJ.
69	Product Information. Parcopa (carbidopa-levodopa). Schwarz Pharma, Mequon, WI.
70	Product Information. Sinemet (carbidopa-levodopa). DuPont Pharmaceuticals, Wilmington, DE.
71	Product Information. Stalevo 50 (carbidopa/entacapone/levodopa). Novartis Pharmaceuticals, East Hanover, NJ.
72	Product Information. Tyzine (tetrahydrozoline). Kenwood Laboratories, Fairfield, NJ.
73	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
74	Sharpe J, Marquez-Julio A, Ashby P "Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report." Can Med Assoc J 107 (1972): 296-300. [PMID: 5056115]
75	Sjoerdsma A "Catecholamine-drug interactions in man." Pharmacol Rev 18 (1966): 673-83. [PMID: 5904180]
76	Teychenne PF, Calne DB, Lewis PJ, Findley LJ "Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase." Clin Pharmacol Ther 18 (1975): 273-7. [PMID: 1164817]
77	van Rossum JM "Potential danger of monoamineoxidase inhibitors and a-methyldopa." Lancet 1 (1963): 950-1. [PMID: 13975251]
78	van Rossum JM, Hurkmans JA "Reversal of the effect of a-Methyldopa by monamine oxidase inhibitors." J Pharm Pharmacol 15 (1963): 493-9. [PMID: 14059015]
79	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
80	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
81	Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
82	Product Information. Xadago (safinamide). US WorldMeds LLC, Louisville , KY.
83	Smookler S, Barmudez AJ "Hypertensive crisis resulting from an MAO inhibitor and an over-the counter appetite suppressant." Ann Emerg Med 11 (1982): 482-4. [PMID: 7114595]
84	Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
85	Gardiner JS, Blough D, Drinkard CR, et al. "Tramadol and seizures: a surveillance study in a managed care population." Pharmacotherapy 20 (2000): 1423-31. [PMID: 11130214]
86	Burke MS, Josephson A, Lightsey A "Combined methylphenidate and imipramine complication." J Am Acad Child Adolesc Psychiatry 34 (1995): 403-4. [PMID: 7751253]
87	Cooper TB, Simpson GM "Concomitant imipramine and methylphenidate administration: a case report." Am J Psychiatry 130 (1973): 721. [PMID: 4701968]
88	Grob CS, Coyle JT "Suspected adverse methylphenidate-imipramine interactions in children." J Dev Behav Pediatr 7 (1986): 265-7. [PMID: 3018047]
89	Gwirtsman HE, Szuba MP, Toren L, Feist M "The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate." Psychopharmacol Bull 30 (1994): 157-64. [PMID: 7831449]
90	Meyers B "Treatment of imipramine-resistant depression and lithium-refractory mania through drug interactions." Am J Psychiatry 135 (1978): 1420-1. [PMID: 707652]
91	Wharton RN, Perel JM, Dayton PG, Malitz S "A potential clinical use for methylphenidate with tricyclic antidepressants." Am J Psychiatry 127 (1971): 1619-25. [PMID: 4998422]
92	Zeidenberg P, Perel JM, Kanzler M, Wharton RN, Malitz S "Clinical and metabolic studies with imipramine in man." Am J Psychiatry 127 (1971): 1321-6. [PMID: 5549923]
93	Gammon GD, Brown TE "Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder." J Child Adolesc Psychopharmacol 3 (1993): 1-10. [PMID: 19630593]
94	Ishii M, Tatsuzawa Y, Yoshino A, Nomura S "Serotonin syndrome induced by augmentation of SSRI with methylphenidate." Psychiatry Clin Neurosci 62 (2008): 246. [PMID: 18412855]
95	Lavretsky H, Kumar A "Methylphenidate augmentation of citalopram in elderly depressed patients." Am J Geriatr Psychiatry 9 (2001): 298-303. [PMID: 11481139]
96	Lavretsky H, Park S, Siddarth P, Kumar A, Reynolds CF 3rd "Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial." Am J Geriatr Psychiatry 14 (2006): 181-5. [PMID: 16473984]
97	Product Information. Concerta (methylphenidate). Alza, Palo Alto, CA.
98	Stoll AL, Pillay SS, Diamond L, Workum SB, Cole JO "Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series." J Clin Psychiatry 57 (1996): 72-6. [PMID: 8591972]
99	Findling RL "Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series." J Child Adolesc Psychopharmacol 6 (1996): 165-75. [PMID: 9231310]
100	Product Information. Metadate CD Capsules (methylphenidate) Celltech Pharmaceuticals, Inc, Applegate, WI.
101	Gulati OD, Dave BT, Gokhale SD, Shah KM "Antagonism of adrenergic neuron blockade in hypertensive subjects." Clin Pharmacol Ther 7 (1966): 510-4. [PMID: 5939974]
102	Gerkens JF, McCulloch MW, Wilson J "Mechanism of the antagonism between guanethidine and dexamphetamine." Br J Pharmacol 35 (1969): 563-72
103	Flegin OT, Morgan DH, Oates JA, Shand DG, Turner P "The mechanism of the reversal of the effect of guanethidine by amphetamines in cat and man." Br J Pharmacol 39 (1970): p253
104	Cavanaugh JH, Griffith JD, Oates JA "Effect of amphetamine on the pressor response to tyramine: formation of p-hydroxynorephedrine from amphetamine in man." Clin Pharmacol Ther 11 (1970): 656
105	Lake CR "Manic psychosis after coffee and phenylpropanolamine." Biol Psychiatry 30 (1991): 401-4. [PMID: 1912131]
106	Reid AA "Pharmacological antagonism between chlorpromazine and phenmetrazine in mental hospital patients." Med J Aust 1 (1964): 187-8. [PMID: 14126355]
107	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
108	Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
109	Product Information. Azstarys (dexmethylphenidate-serdexmethylphenidate). Corium, Inc., Grand Rapids, MI.
110	Achor MB, Extein I "Diet aids, mania, and affective illness" Am J Psychiatry 138 (1981): 392. [PMID: 7468847]
111	Angrist B, Lee HK, Gershon S "The antagonism of amphetamine-induced symptomatology by a neuroleptic." Am J Psychiatry 131 (1974): 817-9. [PMID: 4600629]
112	Casey JF, Hollister LE, Klett CJ, Lasky JJ, Caffey EM "Combined drug therapy of chronic schizophrenics." Am J Psychiatry 177 (1961): 997. [PMID: 13691268]
113	Chouinard G, Ghadirian AM, Jones BD "Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac*C capsule." Can Med Assoc J 119 (1978): 729-31. [PMID: 709472]
114	Cornelius JR, Soloff PH, Reynolds CF, 3d "Paranoia, homicidal behavior, and seizures associated with phenylpropanolamine." Am J Psychiatry 141 (1984): 120-1. [PMID: 6691429]
115	Dewsnap P, Libby G "A case of affective psychosis after routine use of proprietary cold remedy containing phenylpropanolamine" Hum Exp Toxicol 11 (1992): 295-6. [PMID: 1354981]
116	Dietz AJ, Jr "Amphetamine-like reactions to phenylpropanolamine." JAMA 245 (1981): 601-2. [PMID: 7452888]
117	Finton CK, Barton M, Chernow B "Possible adverse effects of phenylpropanolamine (diet pills) on sympathetic nervous system function--caveat emptor!" Mil Med 147 (1982): 1072. [PMID: 6817204]
118	Grieger TA, Clayton AH, Goyer PF "Affective disorder following use of phenylpropanolamine" Am J Psychiatry 147 (1990): 367-8. [PMID: 2309957]
119	Lake CR, Tenglin R, Chernow B, Holloway HC "Psychomotor stimulant-induced mania in a genetically predisposed patient: a review of the literature and report of a case." J Clin Psychopharmacol 3 (1983): 97-100. [PMID: 6341419]
120	Lambert MT "Paranoid psychoses after abuse of proprietary cold remedies." Br J Psychiatry 151: (1987): 548-50. [PMID: 3447673]
121	Marshall RD, Douglas CJ "Phenylpropanolamine-induced psychosis: potential predisposing factors." Gen Hosp Psychiatry 16 (1994): 358-60. [PMID: 7995508]
122	Modell W, Hussar AE "Failure of dextroamphetamine sulfate to incluence eating and sleeping patterns in obese schizophrenic patients." JAMA 193 (1965): 275-8. [PMID: 14310348]
123	Mueller SM "Neurologic complications of phenylpropanolamine use." Neurology 33 (1983): 650-2. [PMID: 6682504]
124	Norvenius G, Widerlov E, Lonnerholm G "Phenylpropanolamine and mental disturbances" Lancet 2 (1979): 1367-8. [PMID: 92706]
125	Product Information. Cylert (pemoline). Abbott Pharmaceutical, Abbott Park, IL.
126	Product Information. Desoxyn (methamphetamine) Abbott Pharmaceutical, Abbott Park, IL.
127	Product Information. Didrex (benzphetamine) Pharmacia and Upjohn, Kalamazoo, MI.
128	Product Information. Fastin (phentermine). SmithKline Beecham, Philadelphia, PA.
129	Product Information. Prelu-2 (phendimetrazine) Boehringer-Ingelheim, Ridgefield, CT.
130	Product Information. Sanorex (mazindol) Novartis Pharmaceuticals, East Hanover, NJ.
131	Product Information. Tenuate (diethylpropion) Aventis Pharmaceuticals, Swiftwater, PA.
132	Schaffer CB, Pauli MW "Psychotic reaction caused by proprietary oral diet agents." Am J Psychiatry 137 (1980): 1256-7. [PMID: 7416278]
133	Sletten IW, Ognjanov V, Menendez S, Sundland D, El-Toumi A "Weight reduction with chlorphentermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy." Curr Ther Res Clin Exp 9 (1967): 570-5. [PMID: 4965506]
134	Stroe AE, Hall J, Amin F "Psychotic episode related to phenylpropanolamine and amantadine in a healthy female." Gen Hosp Psychiatry 17 (1995): 457-8. [PMID: 8714809]
135	Wharton BK "Nasal decongestants and paranoid psychosis." Br J Psychiatry 117 (1970): 439-40. [PMID: 4098187]
136	Product Information. Ritalin LA (methylphenidate). Quality Care Products/Lake Erie Medical , Temperance, MI.
137	Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
138	Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
139	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
140	Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
141	Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
142	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
143	Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
144	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
145	Capstick C, Checkley S, Gray J, Dawe S "Dystonia induced by amphetamine and haloperidol." Br J Psychiatry 165 (1994): 276. [PMID: 7953053]
146	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
147	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
148	Product Information. AdreView (iobenguane I-123). GE Healthcare, Princeton, NJ.
149	Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
150	Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
151	Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.
152	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
153	Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
154	Product Information. ProAmatine (midodrine). Roberts Pharmaceutical Corporation, Eatontown, NJ.
155	Garrettson LK, Perel JM, Dayton PG "Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate." JAMA 207 (1969): 1053-6. [PMID: 5818377]
156	Ghofrani M "Possible phenytoin-methylphenidate interaction." Dev Med Child Neurol 30 (1988): 267. [PMID: 3133263]
157	Kupferberg HJ, Jeffery W, Hunninghake DB "Effect of methylphenidate on plasma anticonvulsant levels." Clin Pharmacol Ther 13 (1972): 201-4. [PMID: 4552820]
158	Mirkin BL, Wright F "Drug interactions: effect of methylphenidate on the disposition of diphenylhydantoin in man." Neurology 21 (1971): 1123-8. [PMID: 5166217]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence